WordNet
- immunogen consisting of a suspension of weakened or dead pathogenic cells injected in order to stimulate the production of antibodies (同)vaccinum
- the 18th letter of the Roman alphabet (同)r
PrepTutorEJDIC
- 牛痘種,痘苗(牛痘を起こすビールスで,天然痘予防のために人体に接種される) / (伝染病の病原菌から作った)ワクチン
- resistance / 17歳以下父兄同伴映画の表示 / rook
- Revised Standard Version改訂標準訳聖書
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. RSウイルス感染症：予防 respiratory syncytial virus infection prevention
- 2. 造血細胞移植の候補者およびレシピエントにおける予防接種 immunizations in hematopoietic cell transplant candidates and recipients
- 3. 小児における肺炎球菌（肺炎レンサ球菌）結合型ワクチン pneumococcal streptococcus pneumoniae conjugate vaccines in children
- 4. 新生児集中治療室（NICU）を退出した幼児のケア care of the neonatal intensive care unit graduate
- 5. 免疫不全症の内科的マネージメント medical management of immunodeficiency
English Journal
- Identification of CCL2, RARRES2 and EFNB2 as host cell factors that influence the multistep replication of respiratory syncytial virus.
- Shirato K1, Ujike M2, Kawase M3, Matsuyama S3.
- Virus research.Virus Res.2015 Dec 2;210:213-26. doi: 10.1016/j.virusres.2015.08.006. Epub 2015 Aug 12.
- Human respiratory syncytial virus (RSV) is a major causative agent of respiratory tract infections in children worldwide. Preterm children or those with underlying cardiopulmonary disorders are at particularly high risk of developing severe and lethal RSV respiratory tract infections; however, there
- PMID 26277777
- Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes.
- Stobart CC1,2, Moore ML1,2.
- Expert review of vaccines.Expert Rev Vaccines.2015 Dec;14(12):1563-72. doi: 10.1586/14760584.2015.1095096. Epub 2015 Oct 5.
- Vaccines represent one of the greatest contributions of the scientific community to global health. Yet, many pathogens remain either unchallenged or inadequately hindered by commercially available vaccines. Respiratory viruses pose distinct and difficult challenges due to their ability to rapidly sp
- PMID 26434947
- Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults.
- Bagga B1, Cehelsky JE2, Vaishnaw A2, Wilkinson T3, Meyers R2, Harrison LM4, Roddam PL1, Walsh EE5, DeVincenzo JP6.
- The Journal of infectious diseases.J Infect Dis.2015 Dec 1;212(11):1719-25. doi: 10.1093/infdis/jiv281. Epub 2015 May 14.
- We studied preexisting respiratory syncytial virus (RSV)-specific serum and nasal antibodies and their correlation with infectivity, viral dynamics, and disease severity in a human experimental infection model. Higher preinoculation serum neutralizing antibody titers and nasal immunoglobulin (Ig) A
- PMID 25977264
Japanese Journal
- Expression of an RSV-gag virus-like particle in insect cell lines and silkworm larvae
- Deo Vipin Kumar,Tsuji Yoshitaka,Yasuda Tomomi,Kato Tatsuya,Sakamoto Naonori,Suzuki Hisao,Park Enoch Y.
- Journal of Virological Methods 177(2), 147-152, 2011-11
- … These VLPs provide a new method for large-scale application in vaccine development and drug delivery systems. …
- NAID 120003256122
- RSV--世界の開発状況 (新時代のワクチン戦略について考える) -- (期待されているこれからのワクチン)
- 堤 裕幸,要藤 裕孝
- 臨床検査 54(11), 1422-1428, 2010
- NAID 40017346675
Related Links
- Respiratory Syncytial Virus Clinical Information: RSV infection can cause a variety of respiratory illnesses. Infants with a lower respiratory tract infection typically have a runny nose and a decrease in appetite before any other ...
- RSV is common during fall, winter and spring. It usually causes mild, cold-like symptoms. But RSV can be serious, especially for infants and older adults. Help protect your child and others from RSV.
Related Pictures
★リンクテーブル★
| リンク元 | 「respiratory syncytial virus vaccine」「呼吸器合胞体ウイルスワクチン」 |
| 関連記事 | 「R」「RS」「RSV」 |
「respiratory syncytial virus vaccine」
RSウイルスワクチン、呼吸器多核体ウイルスワクチン、呼吸器合胞体ウイルスワクチン
「呼吸器合胞体ウイルスワクチン」
「R」
「RS」
「RSV」